14-6-5　ⓔ文献

  1. 水野真一：多発性骨髄腫の腎病変とMGRS．日本内科学会雑誌，2016; 105: 1224–1230.

  2. 日本血液学会編：造血器腫瘍診療ガイドライン 補訂版．http://www.jshem.or.jp/gui-hemail/table.html

  3. Korbet SM, Schwartz MM: Multiple myeloma. J Am Soc Nephrol, 2006; 17: 2533–2545.

  4. Leung N, Bridoux F, et al: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol, 2019; 15: 45–59.

  5. Irish AB, Winearls CG, et al: Presentation and survival of patients with severe renal failure and myeloma. QJM, 1997; 90: 773–780.

  6. Yu ASL, Chertow GM, et al eds: Brenner and Rector’s The Kidney, 11th ed, Elsevier, 2019; 1408–1412.

  7. Mateos MV, Ludwig H, et al: Insights on multiple myeloma treatment strategies. Hemasphere, 2018; 3: e163.